Trial NCT03678090

View at ClinicalTrials.gov 
Org. Study IDs: 2000024040

Last trial update was posted on 2020-03-05

MeSH Interventions

Plasminogen Tissue Plasminogen Activator

MeSH Conditions

Lung Neoplasms Pleural Effusion Pleural Effusion, Malignant

Other Conditions

Cancer, Lung

Stopping Reasons

Local IRB recommended IND exemption from FDA, study timeline not able to be met.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID